A5088568771- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Peripheral Artery Disease Management
- Vascular Procedures and Complications
- Congenital Heart Disease Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Infectious Aortic and Vascular Conditions
- Reconstructive Surgery and Microvascular Techniques
- Cardiac Valve Diseases and Treatments
- Cardiac and Coronary Surgery Techniques
- Orthopaedic implants and arthroplasty
- Muscle and Compartmental Disorders
- Hip and Femur Fractures
Johannes Gutenberg University Mainz
2009-2025
University Medical Center of the Johannes Gutenberg University Mainz
2012-2025
Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie
2010-2015
Background/Objectives: The frozen elephant trunk (FET) technique was introduced as a possible single-stage procedure for treating aortic arch pathologies. However, up to third of patients are reported need subsequent completion (extension). This retrospective analysis aimed evaluate the impact early (within 30 days; EC group) versus late (>30 LC endovascular with thoracic repair (TEVAR) in treated FET. Methods: A single-center, all consecutive period between June 2017 and December 2023...
To assess outcomes of a low-profile thoracic stent-graft in the treatment aortic pathologies.A retrospective analysis all consecutive patients with pathologies treated RelayPro device two university hospitals between October 2018 and July 2019.23 (65% men; mean age 63.4 ± 15 years) were treated. Pathologies included dissections (n = 10), 5 residual type A (22%) B (22%), 6 degenerative aneurysms (26%), 4 penetrating ulcers (17%), erosion, intramural hematoma rupture 1 4% each case). Two cases...
Objectives: To be suitable for patients with challenging anatomy (e.g. angulated or short aneurysm neck), the ENDURANT® stentgraft is equipped proximal anchoring pins to prevent migration. Its flexibility and novel application device have been improved disadvantage on 30% less radial force. This study was initiated evaluate ENDURANT®'s in vivo efficacy discover any product-associated procedure-specific problems.
Introduction: Thoracic endovascular aortic repair for the arch and ascending aorta usually presents technical challenges.
Objectives: Small outflow vessels in below-knee bypass surgery imperatively require autologous veins for the construction of distal anastomoses. However, are not always available sufficient length and quality. In case insufficient vein material with a combination glutaraldehyde denaturated ovine collagen prostheses (Omniflow II®) suitable segments may be considered as an alternative to more commonly used synthetic prostheses.
Introduction: Prosthetic bypass grafts are widely accepted in lower limb surgery case of unsuitable autologous vein. Historical series biological prostheses with denaturated human umbilical vein provided excellent long-term results. The glutaraldehyde ovine collagen prosthesis is currently the only available prosthetic graft for bypass. Early results a consecutive single center presented.
Objectives: Open surgery for aortic arch diseases consists of replacement with vascular prostheses requiring cardiopulmonary bypass and deep hypothermic circulatory arrest. This technique is associated significant morbidity mortality rates, mainly due to neurological complications the sequelae Less invasive surgical techniques have thus been developed. It currently unclear which revascularisation stent-graft device best individual patient. issue was focus our study.
Objectives: We aimed to evaluate the indication for endovascular treatment in patients with persistent true lumen collapse after open surgery acute aortic dissection Type A (AADA).
Objectives: Thoracoabdominal aortic false lumen rupture is a challenging and catastrophic problem after arch surgery with 100% mortality if untreated high open surgery. The objectives were to describe endovascular emergency approaches for occlusion of hybrid replacement. Methods: First Case: An 82-year-old female patient underwent repair type A dissection (TAAD) E-VITA plus stent graft™ (JOTEC GmbH, Hechingen, Germany), followed TEVAR, distal landing zone 5 cm above the celiac trunk...